Schonfeld Strategic Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,997
Closed -$189K 2254
2024
Q2
$189K Buy
+24,997
New +$207K ﹤0.01% 1821
2023
Q1
Sell
-20,121
Closed -$299K 2411
2022
Q4
$299K Buy
20,121
+3,176
+19% +$51.8K ﹤0.01% 1802
2022
Q3
$280K Buy
+16,945
New +$341K ﹤0.01% 2127
2022
Q2
Sell
-18,105
Closed -$425K 2804
2022
Q1
$425K Buy
+18,105
New +$443K ﹤0.01% 1469
2021
Q4
Sell
-10,449
Closed -$297K 2384
2021
Q3
$297K Buy
+10,449
New +$318K ﹤0.01% 1539
2020
Q2
Sell
-74,923
Closed -$872K 1420
2020
Q1
$872K Buy
74,923
+11,457
+18% +$236K 0.06% 413
2019
Q4
$1.76M Buy
+63,466
New +$1.59M 0.04% 361
2019
Q2
Sell
-61,270
Closed -$1.67M 1152
2019
Q1
$1.67M Buy
61,270
+15,876
+35% +$532K 0.06% 387
2018
Q4
$1.5M Buy
+45,394
New +$1.83M 0.06% 379
2018
Q3
Sell
-8,027
Closed -$347K 940
2018
Q2
$347K Buy
+8,027
New +$385K 0.02% 607
2018
Q1
Sell
-6,933
Closed -$370K 895
2017
Q4
$370K Buy
+6,933
New +$327K 0.03% 535

Other funds holding MD

Schonfeld Strategic Advisors's MD Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 24,997 shares — an estimated $189K sold.

Schonfeld Strategic Advisors first reported a position in MD in Q4 2017 and held it in 11 quarters. The position peaked at $1.76M in Q4 2019. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 24,997 Pediatrix Medical shares in Q3 2024, an estimated $189K.
  • Schonfeld Strategic Advisors first reported a position in Pediatrix Medical in Q4 2017 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's Pediatrix Medical position peaked at $1.76M in Q4 2019.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.